U.S. Markets open in 39 hrs, 44 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 09:52 AM EDT | 45.18 | |
|---|---|---|
| Day High 09:30 AM EDT | 46.01 |
|
| Range | 0.83 | |
| Volume | 3.28 M | |
| 30-Day Avg. Vol. | 1.18 M |
|
| Difference | 177.39% | |
| Market Cap. | 66.54 B | |
| Change | 2.42 B | |
| Shares Out. | 1.45 B | |
| Percent Traded | 0.23% | |
| Revenue | 29.55 B | |
| Earnings | 5.59 B | |
| EPS (TTM) | 3.75316 |
| 52-Wk Low 3/17/08 | 35.03 | |
|---|---|---|
| 52-Wk High 7/13/07 | 56.60 |
|
| Range | 21.57 | |
| Prev. Close 7/2/08 | 44.13 | |
| Today's Open | 46.01 | |
| Change | 4.26% | |
| Dividend (TTM) | 1.87 | |
| Div. Yield (TTM) | 4.08% |
|
| Beta | 0.4007 | |
| P/E Ratio (TTM) | 12.28 | |
| P/E Ratio (Fwd.) | 10.00 |
AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's top pharmaceutical firms, AstraZeneca specializes in drugs for gastrointestinal, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.946 12/31/07 | 1.10 12/31/07 |
0.154
Beat
|
| Last Quarter | 1.19 3/31/08 | 1.28 3/31/08 |
0.09
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 7.68 B | 29.56 B |
| Gross Profit | 6.18 B | 23.00 B |
| Operating Income | 2.17 B | 8.33 B |
| Net Income | 1.50 B | 5.60 B |
